Press release
Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight
Global Digital Biomarkers Market
DelveInsight's Digital Biomarkers Market Insights Report offers comprehensive coverage of current and future market trends, competitive dynamics, growth drivers, barriers, and strategic developments across the sector.
The use of digital biomarkers is accelerating worldwide, driven by the rising prevalence of chronic diseases such as cardiovascular, neurological, and metabolic disorders. Aging populations-who are more prone to such conditions-are further boosting demand, while the growing adoption of wearable technologies and continuous innovation from market leaders is fueling market expansion at an unprecedented pace.
Download the Full Digital Biomarkers Market Outlook & Stay Ahead of 17% CAGR Growth - Global Digital Biomarkers Market [https://www.delveinsight.com/report-store/digital-biomarkers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Key Digital Biomarkers Market Highlights
* North America is expected to lead the global digital biomarkers market throughout the forecast period.
* In 2024, physiological biomarkers accounted for the largest segment share.
* The market features prominent digital biomarker companies such as BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene Corporation, PathAI, and others.
Recent Strategic Collaborations in Digital Biomarkers
* June 2025: Agenus and Noetik partnered to develop AI-enabled predictive biomarkers for BOT/BAL using virtual cell biology models to personalize immunotherapy.
* March 2025: Lunit teamed up with the U.S. National Cancer Institute (NCI) to advance AI-driven digital biomarkers for tumor microenvironment and immune phenotyping in cancer research.
* March 2025: BostonGene initiated AI-based molecular profiling initiatives to explore colorectal cancer and multiple myeloma biomarkers through clinical trials.
Explore Strategic Opportunities with Leading Digital Biomarker Innovators - Access the Report Now - Digital Biomarkers Market Forecast [https://www.delveinsight.com/sample-request/digital-biomarkers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
What Are Digital Biomarkers?
Digital biomarkers involve measurable physiological or behavioral data collected using digital devices such as smartphones, wearables, or biosensors. Unlike traditional lab-based biomarkers, they enable remote, real-time, and continuous monitoring of health indicators, including:
* Heart rate variability
* Sleep cycles
* Gait characteristics
* Voice tone
* Typing patterns
These technologies provide deeper visibility into disease progression, treatment response, and daily health patterns outside clinical environments. Their use is expanding across clinical trials, precision medicine, and chronic disease monitoring.
Tap into North America's Dominance - Get Regional Insights & Competitive Intelligence - Digital Biomarkers Competitive Landscape [https://www.delveinsight.com/report-store/digital-biomarkers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Digital Biomarkers Market Insights & Regional Leadership
North America holds a dominant market position due to:
* High chronic disease burden
* A growing elderly population
* Broad use of wearables and connected health devices
* Continuous product innovation and timely regulatory support
These factors collectively reinforce the region's leadership in digital biomarker adoption and commercialization.
Key Digital Biomarkers Market Dynamics
The market's rapid progression is being shaped by:
* Increased integration of wearables and connected health platforms
* Growing emphasis on real-time health tracking and preventive care
* Adoption in clinical trials for adherence monitoring, patient stratification, and real-world evidence generation
* Supportive regulatory frameworks and evolving FDA guidance on digital health
However, challenges such as interoperability, data privacy, device standardization, and secure data management persist. To address these, companies are investing in AI-powered analytics, cloud platforms, and cross-industry partnerships.
Unlock AI-Driven Biomarker Trends & Partnerships - Request Your Market Brief Today - Digital Biomarkers Market Trends [https://www.delveinsight.com/sample-request/digital-biomarkers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Digital Biomarkers Future Outlook
Innovation in sensors, machine learning, virtual monitoring tools, and mobile health apps is expanding digital biomarker applications into:
* Mental health
* Oncology
* Neurology
* Autoimmune and metabolic diseases
Organizations that offer scalable, secure, interoperable technologies are projected to gain a strong competitive edge in this evolving landscape.
Digital Biomarkers Market Segmentation
Digital Biomarkers Market By Product Type:
* Wearable Devices
* Implantable Devices
* Software/Applications
Digital Biomarkers Market By Biomarker Type:
* Physiological
* Behavioral
* Biochemical
Digital Biomarkers Market By Indication:
* Neurological
* Cardiovascular
* Metabolic
* Others
Digital Biomarkers Market By Application:
* Diagnostic
* Monitoring
* Predictive
Digital Biomarkers Market By Region:
* North America Digital Biomarkers Market
* Europe Digital Biomarkers Market
* Asia-Pacific Digital Biomarkers Market
* Rest of World Digital Biomarkers Market
Discover Segment-Wise Growth across Wearables, Diagnostics & Predictive Biomarkers - Get the Full Analysis - Digital Biomarkers Market Size and Forecasts [https://www.delveinsight.com/sample-request/digital-biomarkers-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Digital Biomarkers Market Overview at a Glance
* Study Period: 2022-2032
* CAGR: ~17%
* Forecasted Market Size (2032): ~USD 14 Billion
* Coverage: Global
* Key Companies: BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene, PathAI, and others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-digital-biomarkers-market-set-to-grow-at-17-cagr-by-2032-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight here
News-ID: 4228189 • Views: …
More Releases from ABNewswire
Celiac Disease Pipeline 2025: Groundbreaking Clinical Advancements by 80+ Global …
DelveInsight's Celiac Disease Pipeline Insight, 2025 report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Celiac Disease pipeline landscape. It covers the Celiac Disease Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Celiac Disease Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Celiac Disease Pipeline products in this space.
DelveInsight's "Celiac Disease…
Jacksonville Agency WeekThink Recognized as 2025 Inc. Power Partner Award Winner
WeekThink is a Jacksonville-based digital marketing agency dedicated to helping businesses grow smarter through AI-powered strategy, web design, and local SEO. Founded on the belief that measurable growth comes from data, creativity, and execution, WeekThink partners with healthcare, home service, and lifestyle brands to deliver real results - from more leads and sales to stronger brand presence. Learn more at www.weekthink.com
Jacksonville, FL - October 16, 2025 - WeekThink [https://weekthink.com/], a…
Customer Satisfaction Reports Reflect High Marks for Local Roof Repair Near Lehi
As satisfaction levels rise, local residents are increasingly turning to Mountain Roofers, a company recognized for its precision and customer-focused approach. Reports continue to show that homeowners appreciate the blend of reliability, transparency, and quality workmanship that defines their Local roof repair solutions.
Maintaining a strong and dependable roofing system has become a top priority for homeowners in Lehi, where varying weather conditions demand consistent structural protection. Recent feedback from residents…
Guarding Property Value: How Nature Shield Pest Solutions Keeps Homes in Mexico, …
Nature Shield Pest Solutions provides effective pest control in Mexico, MO, preventing damage from rodents, termites, and pests while preserving home value and offering long-term protection.
Mexico, MO - In Mexico, where homeowners take pride in maintaining the value of their properties, Nature Shield Pest Solutions is making a significant impact by providing reliable and effective pest control Mexico MO [https://natureshieldpestsolutions.com/pest-control-mexico-mo/]. With an expert team and comprehensive pest prevention strategies, Nature…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…
